Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

A decade of experience with a single dose of rabbit antithymocyte globulin or alemtuzumab pretreatment for intestinal and multivisceral transplantation.

Abu-Elmagd KM, Costa G, Bond GJ, Soltys K, Martin L, Koritsky DA, Cunha-Melo JR, Sogawa H, Irish W, Tzakis A, Mazariegos G.

Clin Transpl. 2012:155-66.

PMID:
23721018
2.

5-year results of a prospective, randomized, single-center study of alemtuzumab compared with rabbit antithymocyte globulin induction in simultaneous kidney-pancreas transplantation.

Stratta RJ, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Farney AC.

Transplant Proc. 2014 Jul-Aug;46(6):1928-31. doi: 10.1016/j.transproceed.2014.05.080.

PMID:
25131073
4.

Depleting antibody induction in simultaneous pancreas-kidney transplantation: a prospective single-center comparison of alemtuzumab versus rabbit anti-thymocyte globulin.

Stratta RJ, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Doares W, Kaczmorski S, Farney AC.

Expert Opin Biol Ther. 2014 Dec;14(12):1723-30. doi: 10.1517/14712598.2014.953049. Epub 2014 Aug 25.

PMID:
25156622
5.

Evolutionary experience with immunosuppression in pediatric intestinal transplantation.

Bond GJ, Mazariegos GV, Sindhi R, Abu-Elmagd KM, Reyes J.

J Pediatr Surg. 2005 Jan;40(1):274-9; discussion 279-80.

PMID:
15868597
6.

A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation.

Farney AC, Doares W, Rogers J, Singh R, Hartmann E, Hart L, Ashcraft E, Reeves-Daniels A, Gautreaux M, Iskandar SS, Moore P, Adams PL, Stratta RJ.

Transplantation. 2009 Sep 27;88(6):810-9. doi: 10.1097/TP.0b013e3181b4acfb.

PMID:
19920781
7.

Comparison of alemtuzumab vs. antithymocyte globulin induction therapy in primary non-sensitized renal transplant patients treated with rapid steroid withdrawal.

Saull HE, Enderby CY, Gonwa TA, Wadei HM.

Clin Transplant. 2015 Jul;29(7):573-80. doi: 10.1111/ctr.12532. Epub 2015 Mar 24.

PMID:
25711849
8.

Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period.

Zanfi C, Lauro A, Cescon M, Dazzi A, Ercolani G, Grazi GL, Zanello M, Vivarelli M, Del Gaudio M, Ravaioli M, Cucchetti A, Vetrone G, Tuci F, Di Gioia P, Lazzarotto T, D'Errico A, Bagni A, Faenza S, Siniscalchi A, Pironi L, Pinna AD.

Transplant Proc. 2010 Jan-Feb;42(1):35-8. doi: 10.1016/j.transproceed.2009.12.019.

PMID:
20172276
9.

Evolution of the immunosuppressive strategies for the intestinal and multivisceral recipients with special reference to allograft immunity and achievement of partial tolerance.

Abu-Elmagd KM, Costa G, Bond GJ, Wu T, Murase N, Zeevi A, Simmons R, Soltys K, Sindhi R, Stein W, Demetris A, Mazariegos G.

Transpl Int. 2009 Jan;22(1):96-109. doi: 10.1111/j.1432-2277.2008.00785.x. Epub 2008 Oct 24. Review.

10.

Lymphoproliferative disorders and de novo malignancies in intestinal and multivisceral recipients: improved outcomes with new outlooks.

Abu-Elmagd KM, Mazariegos G, Costa G, Soltys K, Bond G, Sindhi R, Green M, Jaffe R, Wu T, Koritsky D, Matarese L, Schuster B, Martin L, Dvorchik I, Nalesnik MA.

Transplantation. 2009 Oct 15;88(7):926-34. doi: 10.1097/TP.0b013e3181b7509c.

PMID:
19935465
11.

Alemtuzumab induction therapy in highly sensitized kidney transplant recipients.

Lü TM, Yang SL, Wu WZ, Tan JM.

Chin Med J (Engl). 2011 Mar;124(5):664-8.

PMID:
21518554
12.

Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning.

Shapiro R, Jordan ML, Basu A, Scantlebury V, Potdar S, Tan HP, Gray EA, Randhawa PS, Murase N, Zeevi A, Demetris AJ, Woodward J, Marcos A, Fung JJ, Starzl TE.

Ann Surg. 2003 Oct;238(4):520-5; discussion 525-7.

13.

Induction immunosuppression with thymoglobulin and rituximab in intestinal and multivisceral transplantation.

Vianna RM, Mangus RS, Fridell JA, Weigman S, Kazimi M, Tector J.

Transplantation. 2008 May 15;85(9):1290-3. doi: 10.1097/TP.0b013e31816dd450.

PMID:
18475186
14.

Impact of small variations in the delivered dose of rabbit antithymocyte induction therapy in kidney transplantation with early corticosteroid withdrawal.

Tsapepas DS, Mohan S, Tanriover B, Dube G, Crew RJ, Cohen DJ, Hardy MA, Sandoval PR, Ratner LE.

Transplantation. 2012 Aug 27;94(4):325-30. doi: 10.1097/TP.0b013e318257ad1a.

PMID:
22814328
15.

Renal transplantation in the setting of early steroid withdrawal: a comparison of rabbit antithymocyte globulin induction dosing in two eras.

Rogers CC, Asipenko N, Horwedel T, Gautam S, Goldfarb-Rumyantzev AS, Pavlakis M, Johnson SR, Karp SJ, Evenson A, Khwaja K, Hanto DW, Mandelbrot DA.

Am J Nephrol. 2013;38(5):397-404. doi: 10.1159/000355620. Epub 2013 Oct 26.

PMID:
24192457
16.

Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy.

McCurry KR, Iacono A, Zeevi A, Yousem S, Girnita A, Husain S, Zaldonis D, Johnson B, Hattler BG, Starzl TE.

J Thorac Cardiovasc Surg. 2005 Aug;130(2):528-37.

17.

Steroid-free tacrolimus monotherapy after pretransplantation thymoglobulin or Campath and laparoscopy in living donor renal transplantation.

Tan HP, Kaczorowski D, Basu A, McCauley J, Marcos A, Donaldson J, Unruh M, Randhawa P, Zeevi A, Shapiro R.

Transplant Proc. 2005 Dec;37(10):4235-40.

PMID:
16387087
18.

Promising early results with immunosuppression using rabbit anti-thymocyte globulin and steroids with delayed introduction of tacrolimus in adult liver transplant recipients.

Tector AJ, Fridell JA, Mangus RS, Shah A, Milgrom M, Kwo P, Chalasani N, Yoo H, Rouch D, Liangpunsakul S, Herring S, Lumeng L.

Liver Transpl. 2004 Mar;10(3):404-7.

19.

Comparison of clinical outcome of low-dose and high-dose rabbit antithymocyte globulin induction therapy in renal transplantation: a single-center experience.

Yang JW, Wang JN, Men TY, Zhang XM, Li XD, Shen B, Li GY, Chen DD.

Ann Transplant. 2014 Jun 6;19:277-82. doi: 10.12659/AOT.890069.

20.

Five hundred intestinal and multivisceral transplantations at a single center: major advances with new challenges.

Abu-Elmagd KM, Costa G, Bond GJ, Soltys K, Sindhi R, Wu T, Koritsky DA, Schuster B, Martin L, Cruz RJ, Murase N, Zeevi A, Irish W, Ayyash MO, Matarese L, Humar A, Mazariegos G.

Ann Surg. 2009 Oct;250(4):567-81. doi: 10.1097/SLA.0b013e3181b67725.

PMID:
19730240

Supplemental Content

Support Center